These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34522901)

  • 21. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoantigen prediction from genomic and transcriptomic data.
    Battaglia S
    Methods Enzymol; 2020; 635():267-281. PubMed ID: 32122550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of RNA Sequencing Data Using CLC Genomics Workbench.
    Liu CH; Di YP
    Methods Mol Biol; 2020; 2102():61-113. PubMed ID: 31989550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual RNA-Sequencing of
    Pisu D; Huang L; Rin Lee BN; Grenier JK; Russell DG
    STAR Protoc; 2020 Dec; 1(3):100123. PubMed ID: 33377017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.
    Cheng R; Xu Z; Luo M; Wang P; Cao H; Jin X; Zhou W; Xiao L; Jiang Q
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35279714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol to estimate cell type proportions from bulk RNA-seq using DAISM-DNN
    Lin Y; Wu S; Xiao X; Zhao J; Wang M; Li H; Wang K; Zhang M; Zheng F; Yang W; Zhang L; Han J; Yu R
    STAR Protoc; 2022 Sep; 3(3):101587. PubMed ID: 35942344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens.
    Bais P; Namburi S; Gatti DM; Zhang X; Chuang JH
    Bioinformatics; 2017 Oct; 33(19):3110-3112. PubMed ID: 28605406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Processing single-cell RNA-seq data for dimension reduction-based analyses using open-source tools.
    Chen B; Ramirez-Solano MA; Heiser CN; Liu Q; Lau KS
    STAR Protoc; 2021 Jun; 2(2):100450. PubMed ID: 33982010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Network analysis of TCGA and GTEx gene expression datasets for identification of trait-associated biomarkers in human cancer.
    Chen HM; MacDonald JA
    STAR Protoc; 2022 Mar; 3(1):101168. PubMed ID: 35199033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA Transcription and Splicing Errors as a Source of Cancer Frameshift Neoantigens for Vaccines.
    Shen L; Zhang J; Lee H; Batista MT; Johnston SA
    Sci Rep; 2019 Oct; 9(1):14184. PubMed ID: 31578439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of mouse ovarian follicles for single-cell RNA-seq and in vitro culture.
    Qian J; Zhu R; Yan R; Long X; Guo F
    STAR Protoc; 2022 Sep; 3(3):101537. PubMed ID: 35830306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Processing Human Thymic Tissue for Single Cell RNA-Seq.
    Le J; Ha VL; Luong A; Parekh C
    STAR Protoc; 2020 Sep; 1(2):100090. PubMed ID: 33111122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of exitron-containing homeobox genes in cancer.
    de Faria Poloni J; Feltes BC
    WIREs Mech Dis; 2023; 15(3):e1606. PubMed ID: 36974895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.
    Robertson AG; Yau C; Carrot-Zhang J; Damrauer JS; Knijnenburg TA; Chambwe N; Hoadley KA; Kemal A; Zenklusen JC; Cherniack AD; Beroukhim R; Zhou W
    STAR Protoc; 2021 Jun; 2(2):100483. PubMed ID: 33982016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis.
    Wen B; Li K; Zhang Y; Zhang B
    Nat Commun; 2020 Apr; 11(1):1759. PubMed ID: 32273506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protocol for proteogenomic dissection of intronic splicing enhancer interactome for prediction of individualized cancer prognosis.
    Wang L; Wrobel JA; Xie L; Chen X
    STAR Protoc; 2021 Mar; 2(1):100338. PubMed ID: 33644773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SpliceAid 2: a database of human splicing factors expression data and RNA target motifs.
    Piva F; Giulietti M; Burini AB; Principato G
    Hum Mutat; 2012 Jan; 33(1):81-5. PubMed ID: 21922594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.